Inhibrx Biosciences, Inc. (INBX)

Inhibrx Biosciences Revenue

Inhibrx Biosciences had revenue of $1.30M in the quarter ending June 30, 2025, with 1,200.00% growth. This brings the company's revenue in the last twelve months to $1.40M, down -24.45% year-over-year. In the year 2024, Inhibrx Biosciences had annual revenue of $200.00K, down -88.89%.

• Revenue (ttm): $1.40M
• Revenue Growth: -24.45%
• P/S Ratio: 293.24
• Revenue / Employee: $8,696
• Employees: 161
• Market Cap: 389.01M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	200.00K	-1.60M	-88.89%
Dec 31, 2023	1.80M	485.00K	36.88%
Dec 31, 2022	1.32M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.